Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Net Income (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Net Income data on record, last reported at $36.4 million in Q4 2025.

  • For Q4 2025, Net Income rose 1043.64% year-over-year to $36.4 million; the TTM value through Dec 2025 reached $114.1 million, up 2787.59%, while the annual FY2025 figure was $64.7 million, 249.35% up from the prior year.
  • Net Income reached $36.4 million in Q4 2025 per PAHC's latest filing, roughly flat from $36.3 million in the prior quarter.
  • Across five years, Net Income topped out at $36.4 million in Q4 2025 and bottomed at -$27.3 million in Q2 2024.
  • Average Net Income over 5 years is $10.9 million, with a median of $11.1 million recorded in 2021.
  • Peak YoY movement for Net Income: crashed 733.68% in 2024, then skyrocketed 1043.64% in 2025.
  • A 5-year view of Net Income shows it stood at $23.5 million in 2021, then tumbled by 69.36% to $7.2 million in 2022, then plummeted by 82.33% to $1.3 million in 2023, then skyrocketed by 150.0% to $3.2 million in 2024, then surged by 1043.64% to $36.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were $36.4 million in Q4 2025, $36.3 million in Q3 2025, and $20.5 million in Q2 2025.